Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress

Go back to Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress
(NASDAQ: RVMD) Delayed: 168.70 +2.89 (1.74%)
Previous Close $165.81    52 Week High
Open $163.30    52 Week Low
Day High $171.25    P/E N/A 
Day Low $163.05    EPS
Volume 1,829,017